Key takeaway points The use of GLP-1 receptor agonists have become increasingly popular due to its weight loss benefit and the current production levels of these products are well below the demand levels globally
This study adds to a growing body of evidence suggesting that GLP-1 receptor agonistsmedications originally designed for diabetes and obesitymay have broader neuroprotective effects, said Merrill
In some cases, additional tests, such as immunohistochemistry or molecular testing, may be performed on the biopsy sample to further characterize the tumor and guide personalized treatment approaches
209 In a randomized, double-blind, placebo-controlled trial, 68 women with hypothyroidism received either 30 mg zinc and 200 mcg selenium, zinc and placebo, selenium and placebo, or placebo alone for 12 weeks
The association of fish consumption and its urinary metabolites with cardiovascular risk factors: the International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP)